These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 22923667)
1. Transthyretin predicts cardiovascular outcome in hemodialysis patients with type 2 diabetes. Henze A; Espe KM; Wanner C; Krane V; Raila J; Hocher B; Schweigert FJ; Drechsler C Diabetes Care; 2012 Nov; 35(11):2365-72. PubMed ID: 22923667 [TBL] [Abstract][Full Text] [Related]
2. Range of serum transthyretin levels in hemodialysis patients at a high risk of 1-year mortality: A retrospective cohort study. Kumagai E; Hosohata K; Furumachi K; Takai S Ther Apher Dial; 2022 Aug; 26(4):743-748. PubMed ID: 34845841 [TBL] [Abstract][Full Text] [Related]
3. Validation of serum transthyretin (prealbumin) as a nutritional parameter in hemodialysis patients. Duggan A; Huffman FG J Ren Nutr; 1998 Jul; 8(3):142-9. PubMed ID: 9724504 [TBL] [Abstract][Full Text] [Related]
4. Is serum transthyretin a reliable marker of nutritional status in patients with end-stage renal disease? Fellah H; Omar S; Feki M; Abderrahim E; Ben Abdallah T; Massy ZA; Lacour B; Ben Maiz H; Kaabachi N; Mebazaa A Clin Biochem; 2008 May; 41(7-8):493-7. PubMed ID: 18242169 [TBL] [Abstract][Full Text] [Related]
5. Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin. Hanson JLS; Arvanitis M; Koch CM; Berk JL; Ruberg FL; Prokaeva T; Connors LH Circ Heart Fail; 2018 Feb; 11(2):e004000. PubMed ID: 29449366 [TBL] [Abstract][Full Text] [Related]
6. Cysteinylated transthyretin as a discriminator of cardiovascular risk in patients with diabetes mellitus. Wakabayashi I; Marumo M; Nonaka D; Lee LJ; Mukai J; Ohki M; Tanaka K; Uchida K Clin Chim Acta; 2017 Jul; 470():46-50. PubMed ID: 28434967 [TBL] [Abstract][Full Text] [Related]
7. Body fat mass is correlated with serum transthyretin levels in maintenance hemodialysis patients. Matsuura S; Shirai Y; Kubo M; Nayama C; Okitsu M; Oiwa Y; Yasui S; Suzuki Y; Murata T; Ishikawa E; Miki C; Hamada Y J Med Invest; 2017; 64(3.4):222-227. PubMed ID: 28954986 [TBL] [Abstract][Full Text] [Related]
8. Ineffectiveness of dialysis in transthyretin (TTR) clearance in familial amyloid polyneuropathy type I, in spite of lower stability of the TTR Met30 variant. Beirão I; Lobato L; Riedstra S; Costa PM; Pimentel S; Guimarães S Clin Nephrol; 1999 Jan; 51(1):45-9. PubMed ID: 9988146 [TBL] [Abstract][Full Text] [Related]
9. Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients. Chertow GM; Goldstein-Fuchs DJ; Lazarus JM; Kaysen GA Kidney Int; 2005 Dec; 68(6):2794-800. PubMed ID: 16316355 [TBL] [Abstract][Full Text] [Related]
10. Biomarkers of inflammation and malnutrition associated with early death in healthy elderly people. Carriere I; Dupuy AM; Lacroux A; Cristol JP; Delcourt C; J Am Geriatr Soc; 2008 May; 56(5):840-6. PubMed ID: 18410327 [TBL] [Abstract][Full Text] [Related]
11. Serum retinol binding protein 4 level is related with renal functions in Type 2 diabetes. Akbay E; Muslu N; Nayir E; Ozhan O; Kiykim A J Endocrinol Invest; 2010 Nov; 33(10):725-9. PubMed ID: 20436266 [TBL] [Abstract][Full Text] [Related]
12. Serial prealbumin levels as predictors of outcomes in a retrospective cohort of peritoneal and hemodialysis patients. Holland DC; Meers C; Lawlor ME; Lam M J Ren Nutr; 2001 Jul; 11(3):129-38. PubMed ID: 11466663 [TBL] [Abstract][Full Text] [Related]
13. Observations with regard to the National Kidney Foundation K/DOQI clinical practice guidelines concerning serum transthyretin in chronic renal failure. Kopple JD; Mehrotra R; Suppasyndh O; Kalantar-Zadeh K Clin Chem Lab Med; 2002 Dec; 40(12):1308-12. PubMed ID: 12553435 [TBL] [Abstract][Full Text] [Related]
14. Plasma Retinol Concentration Is Mainly Driven by Transthyretin in Hemodialysis Patients. Bataille S; Landrier JF; Astier J; Cado S; Sallette J; Serveaux M; Burtey S; Cohen J; Tournier C; Tourniaire F; Darmon P J Ren Nutr; 2017 Nov; 27(6):395-401. PubMed ID: 28688921 [TBL] [Abstract][Full Text] [Related]
15. Transthyretin as a marker to predict outcome in critically ill patients. Devakonda A; George L; Raoof S; Esan A; Saleh A; Bernstein LH Clin Biochem; 2008 Oct; 41(14-15):1126-30. PubMed ID: 18655780 [TBL] [Abstract][Full Text] [Related]
16. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus. Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C; Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus--a post hoc analysis of the 4D Study. Kollerits B; Krane V; Drechsler C; Lamina C; März W; Ritz E; Wanner C; Kronenberg F; J Intern Med; 2012 Dec; 272(6):592-600. PubMed ID: 22891946 [TBL] [Abstract][Full Text] [Related]
18. Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie). Drechsler C; Grootendorst DC; Pilz S; Tomaschitz A; Krane V; Dekker F; März W; Ritz E; Wanner C Am J Kidney Dis; 2011 Oct; 58(4):599-607. PubMed ID: 21820222 [TBL] [Abstract][Full Text] [Related]
19. The relationship of blood neutrophil-to-lymphocyte ratio with nutrition markers and health outcomes in hemodialysis patients. Diaz-Martinez J; Campa A; Delgado-Enciso I; Hain D; George F; Huffman F; Baum M Int Urol Nephrol; 2019 Jul; 51(7):1239-1247. PubMed ID: 31089947 [TBL] [Abstract][Full Text] [Related]
20. The association between parathyroid hormone and mortality in dialysis patients is modified by wasting. Drechsler C; Krane V; Grootendorst DC; Ritz E; Winkler K; März W; Dekker F; Wanner C; Nephrol Dial Transplant; 2009 Oct; 24(10):3151-7. PubMed ID: 19474272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]